Popular migraine drug recalled over potentially serious bacteria risk

Brand name drug Relpax, a tryptamine-based medication in the triptan class of drugs, has been voluntarily recalled by the pharmaceutical company Pfizer over the potential risk of ‘microbiological’ contamination. The FDA detailed the recall this week, explaining that migraine sufferers who consume a contaminated pill may be at risk of potentially serious infections, as well as other issues like an … Continue reading